Bozidar V.
- Country
- Croatia
- Department
- Practice
Research Overview
- Long-term safety and tolerability of zigakibart in adults with primary IgA nephropathy: an open-label extension study
- Phase II Basket Trial of BI 764198 in Adults and Adolescents With Proteinuric Kidney Diseases
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Felzartamab in Adults with IgA Nephropathy (299IG301 / PREVAIL)
Data & Insights
Has run more than one trial at 23 of 133 partner sites.
Specializations
Oncology
Clinical research activity includes non-small cell lung cancer, cutaneous squamous cell carcinoma, renal cell carcinoma, melanoma, and advanced solid tumors with KRAS G12C alterations, with interest in immunotherapy-based and targeted treatment strategies.
- Advanced and metastatic NSCLC
- Non-clear cell renal cell carcinoma
- Cutaneous squamous cell carcinoma
- Melanoma
The therapeutic focus extends to checkpoint-based combinations, precision oncology, and treatment options for previously treated or untreated advanced malignancies.
Dermatology and Immune-Mediated Skin Disease
Research involvement covers atopic dermatitis, alopecia areata, hidradenitis suppurativa, chronic spontaneous urticaria, prurigo nodularis, and bullous pemphigoid, reflecting a strong therapeutic interest in inflammatory and autoimmune skin disorders.
- Atopic dermatitis
- Alopecia areata
- Hidradenitis suppurativa
- Chronic spontaneous urticaria
Additional activity includes studies in prurigo nodularis and other immune-mediated dermatologic conditions requiring advanced targeted therapy.
Gastroenterology and Inflammatory Bowel Disease
Trial activity includes ulcerative colitis and Crohn’s disease, with a clear emphasis on moderate to severe disease control and intestinal inflammation.
- Ulcerative colitis
- Crohn’s disease
- Inflammatory bowel disease
- Endoscopic disease activity
Research also extends to biosimilar and novel immunologic approaches for chronic relapsing gastrointestinal disease.
Cardiometabolic and Heart Failure Disorders
Clinical interests include atherosclerotic cardiovascular disease, chronic heart failure, heart failure with preserved ejection fraction, heart failure with mildly reduced ejection fraction, hypertension, and type 2 diabetes.
- Cardiovascular disease
- Heart failure
- Hypertension
- Type 2 diabetes
The therapeutic landscape includes lipid-lowering, anti-inflammatory, and cardio-renal approaches aimed at reducing cardiovascular risk and worsening heart failure.
Autoimmune and Systemic Inflammatory Disease
Research involvement also includes systemic lupus erythematosus, IgA nephropathy, immune thrombocytopenia, Behçet’s syndrome, antiphospholipid syndrome, dermatomyositis, and immune-mediated necrotizing myopathy.
- Systemic lupus erythematosus
- IgA nephropathy
- Immune thrombocytopenia
- Systemic inflammatory disease
Interest also extends to bronchiectasis, chronic obstructive pulmonary disease, and moderate to severe asthma, linking immune modulation with respiratory and multisystem inflammatory care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.